Methods of estimating vancomycin use in an inpatient setting: Days of therapy versus therapeutic drug monitoring-based exposure days

  • Shutaro Murakami
  • , Junko Hiroi
  • , Yasuharu Tokuda
  • , Ed Casabar
  • , Hitoshi Honda

Research output: Contribution to journalArticlepeer-review

Abstract

Underestimating antimicrobial use based on days of therapy (DOT) is recognized for certain antimicrobial agents. We investigated the difference between DOT and therapeutic drug monitoring (TDM)-based exposure days in estimating vancomycin use and demonstrated that DOT may underestimate vancomycin exposure by ∼10%.

Original languageEnglish
Pages (from-to)375-379
Number of pages5
JournalInfection Control and Hospital Epidemiology
Volume40
Issue number3
DOIs
Publication statusPublished - 01-03-2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Methods of estimating vancomycin use in an inpatient setting: Days of therapy versus therapeutic drug monitoring-based exposure days'. Together they form a unique fingerprint.

Cite this